Article

The metabolic syndrome: a global public health problem and a new definition.

International Diabetes Institute, Melbourne, Australia.
Journal of atherosclerosis and thrombosis (Impact Factor: 2.77). 02/2005; 12(6):295-300. DOI: 10.5551/jat.12.295
Source: PubMed

ABSTRACT The constellation of metabolic abnormalities including centrally distributed obesity, decreased high-density lipoprotein cholesterol (HDL-C), elevated triglycerides, elevated blood pressure (BP), and hyperglycaemia is known as the metabolic syndrome. Associated with a 3 fold and 2 fold increase in type 2 diabetes and cardiovascular disease (CVD), respectively, it is thought to be a driver of the modern day epidemics of diabetes and CVD and has become a major public health challenge around the world. Since its initial description, several definitions of the syndrome have emerged. Each of these definitions used differing sets of criteria, which reflected contrasting views on pathogenic mechanisms and the need for clinical usefulness. The use of these definitions to conduct research into the metabolic syndrome in diverse populations resulted in wide ranging prevalence rates, inconsistencies and confusion, and spurred on the vigorous debate regarding how the metabolic syndrome should be defined. In response to this controversy, the International Diabetes Federation (IDF) has recently proposed a new definition, which is applicable to populations around the world. It is envisaged that the development of the new definition for the metabolic syndrome will help resolve the confusion caused by the number of earlier attempts to define this important entity.

1 Bookmark
 · 
342 Views
  • Journal of Endocrinology, Metabolism and Diabetes of South Africa 08/2014; 17(2):85-90. DOI:10.1080/22201009.2012.10872282
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim: To identify important single nucleotide polymorphisms (SNPs) in the ABCA1 and ABCC8 (SUR1) genes and determine if they are associated with metabolic syndorome (MetS). Materials and methods: Fifty-eight subjects fulfilling all 5 MetS criteria were chosen from 4809 subjects who participated in our screening study (Trabzon MetS study). Forty-three subjects who did not fulfill any MetS criteria were chosen as the control group. Genotyping of the samples after DNA isolation was performed by direct sequencing. For SNP analysis, exons 7, 15, 19, 36, 41, and 49 for ABCA1 and exons 16 and 18 for ABCC8 were selected. Results: The most important SNPs in the present study were R219K (AGG-AAG for codon 219 in exon 7) for ABCA1, and 16-3t (CTT-TTT for codon 723 in exon 16) and GAG-GAG for codon 760 in exon 18 for ABCC8. Conclusion: It was concluded that MetS may be associated with polymorphisms in ABCA1 and ABCC8.
    Turkish Journal of Medical Sciences 02/2013; DOI:10.3906/sag-1204-23 · 0.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Several central nervous disorders are associated with metabolic syndrome (MetS) and type 2 diabetes. Reduction in brain-derived neurotrophic factor (BDNF) is involved in the mechanism of central nervous dysfunction. BDNF is up-regulated after exercise, but it is not known whether increased BDNF is related to increases in muscle strength. In the present study, subjects with MetS or type 2 diabetes were enrolled in an exercise program. All participants underwent an indoor bicycle exercise program for twelve weeks. Serum BDNF was determined after overnight fasting. Muscle strength was assessed by extension of the dominant lower extremity. A total of 33 subjects were enrolled in this study. The body mass index did not change significantly (from 30.4±6.0 to 30.2±5.8kg/m(2), P=0.436), but serum BDNF increased significantly (from 17.1±9.1 to 24.2±10.7ng/mL, P<0.001) after the study. The exercise-associated BDNF was significantly correlated with the increased strength in lower-extremity extension test (r=0.54, P=0.001). Using multivariate regression analysis, muscle-strength increment, but not body-weight change, was an independent factor for serum BDNF (95% CI=0.009-0.044, P=0.005). After a twelve-week program of stationary bicycle exercise, serum BDNF concentration increased, and this change was positively correlated with muscle strength of lower-extremity extension, but not body weight. (Trial registration: NCT02268292, ClinicalTrials.gov). Copyright © 2015 Elsevier Inc. All rights reserved.
    Journal of Diabetes and its Complications 02/2015; DOI:10.1016/j.jdiacomp.2015.01.014 · 1.93 Impact Factor

Full-text (2 Sources)

Download
3,132 Downloads
Available from
Jun 4, 2014